Silk Road Medical Inc financial data

Symbol
SILK on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1213 Innsbruck Dr., Sunnyvale, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 894 % -3.55%
Quick Ratio 105 % +28.8%
Debt-to-equity 72.9 % -7.49%
Return On Equity -37.3 % +5.78%
Return On Assets -21.6 % +2.57%
Operating Margin -31.4 % +3.56%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.6M shares +4.63%
Common Stock, Shares, Outstanding 40.6M shares +4.64%
Entity Public Float 1.2B USD -7.69%
Common Stock, Value, Issued 41K USD +5.13%
Weighted Average Number of Shares Outstanding, Basic 39.6M shares +2.21%
Weighted Average Number of Shares Outstanding, Diluted 39.6M shares +2.21%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 191M USD +17.5%
Research and Development Expense 42.7M USD +9.7%
Operating Income (Loss) -60.2M USD -13.4%
Net Income (Loss) Attributable to Parent -56.5M USD -6.92%
Earnings Per Share, Basic -1.44 USD/shares -2.86%
Earnings Per Share, Diluted -1.44 USD/shares -2.86%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.6M USD -20.3%
Cash, Cash Equivalents, and Short-term Investments 184M USD -8.75%
Accounts Receivable, after Allowance for Credit Loss, Current 26.3M USD +22%
Inventory, Net 29.7M USD +55.7%
Assets, Current 241M USD +3.22%
Property, Plant and Equipment, Net 8.38M USD -3.04%
Operating Lease, Right-of-Use Asset 5.92M USD -15.8%
Other Assets, Noncurrent 6.23M USD -15.1%
Assets 270M USD +2.45%
Accounts Payable, Current 3.69M USD -30.8%
Accrued Liabilities, Current 27.9M USD +48.6%
Contract with Customer, Liability, Current 270K USD +22.7%
Liabilities, Current 31.6M USD +31%
Operating Lease, Liability, Noncurrent 6.56M USD -17.9%
Other Liabilities, Noncurrent 7.4M USD -14.4%
Liabilities 115M USD +6.74%
Accumulated Other Comprehensive Income (Loss), Net of Tax -122K USD +63.1%
Retained Earnings (Accumulated Deficit) -430M USD -15.1%
Stockholders' Equity Attributable to Parent 155M USD -0.53%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 155M USD -0.53%
Liabilities and Equity 270M USD +2.45%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.3M USD -26.1%
Net Cash Provided by (Used in) Financing Activities 1.11M USD +561%
Net Cash Provided by (Used in) Investing Activities 17.7M USD +191%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 40.6M shares +4.64%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.42M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 22.6M USD -20.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.44M USD +1.55%
Deferred Tax Assets, Valuation Allowance 123M USD +10.4%
Deferred Tax Assets, Gross 126M USD +10.1%
Operating Lease, Liability 8.32M USD -13.8%
Payments to Acquire Property, Plant, and Equipment 388K USD +35.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -56.3M USD -5.87%
Lessee, Operating Lease, Liability, to be Paid 9.83M USD -16.9%
Property, Plant and Equipment, Gross 15.7M USD +8.85%
Operating Lease, Liability, Current 1.76M USD +5.45%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.26M USD +13.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.13M USD +115%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +15.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.51M USD -30.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.07M USD -2.91%
Deferred Tax Assets, Operating Loss Carryforwards 85.9M USD +3.84%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 4.36M USD +15.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.07M USD +76.3%
Additional Paid in Capital 585M USD +10.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 41.3M USD +25.3%
Interest Expense 6.91M USD +0.89%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%